SCHEMBL8643964

SCHEMBL8643964

N#Cc1c(Sc2cccc(N)c2)cccc1[N+](=O)[O-]

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 12/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PDE7B Q9NP56 2/20 0.39
▸ IDO1 P14902 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CUL4A Q13619 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2421409 0.85 PDE7A (0.49) PDE7ASMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL8642795 0.84 SMN1; SMN2 (0.48) PDE7ASMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL8641570 0.83 TDP1 (0.40) PDE7ASMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL8641177 0.81 LMNA (0.43) PDE7ASMN1; SMN2ALDH1A1MAPTKDM4E
SCHEMBL8645461 0.79 ALDH1A1 (0.46) PDE7ASMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL8642759 0.77 CYP19A1 (0.42) SMN1; SMN2ALDH1A1MAPTHPGDKDM4E
SCHEMBL2415981 0.74 TDP1 (0.44) PDE7ASMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL2960443 0.73 PDE7A (0.71) PDE7AALDH1A1MAPTPDE7BTDP1
SCHEMBL618153 0.73 TDP1 (0.54) SMN1; SMN2ALDH1A1HPGDTDP1TSHR
SCHEMBL2413571 0.72 SMN1; SMN2 (0.46) PDE7ASMN1; SMN2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723452-A Therapeutic benzonitriles GLAXO WELLCOME INC. (US) 1998-03-03 — — US disclosed
Send feedback